This is a non-core endpoint: only basic statistics are computed.
Benign neoplasm of male genital organs
CD2_BENIGN_MALE_GEN_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
|
1. Apply sex-specific ruleonly males |
- |
2. Check conditionsNone |
|
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
- |
4. Check minimum number of eventsNone |
- |
5. Include endpoints |
- |
6. Filter based on genotype QC (FinnGen only)None |
- |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
Extra metadata
- Level in the ICD hierarchy
- 2
- First used in FinnGen datafreeze
- DF3
- Parent code in ICD-10
- D10-D36
- Name in latin
- Neoplasmata benigna organorum genitalium masculinorum
Similar endpoints
↥List of similar endpoints to
Benign neoplasm of male genital organs
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm of male genital organs
- Benign neoplasms
- Benign neoplasms
- Neoplasms
- Any event in hilmo or specialist outpatient
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: script not run.
No upset table: script not run.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 737 | - | 737 |
| Unadjusted period prevalence (%) | 0.32 | - | 0.32 |
| Median age at first event (years) | 58.18 | - | 58.18 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 673
- Matched controls
- 6729
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
D29.1
ICD-10 Finland
Benign neoplasm: Prostate
364.7
212.5
204
8
C61
ICD-10 Finland
Malignant neoplasm of prostate
495.7
161.8
155
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
157.7
145
*
D29.2
ICD-10 Finland
Benign neoplasm: Testis
+∞
110.5
103
*
D29.4
ICD-10 Finland
Benign neoplasm: Scrotum
+∞
108.3
101
*
D29.3
ICD-10 Finland
Benign neoplasm: Epididymis
+∞
91.8
86
*
116
Kela drug reimbursment
Prostate cancer
+∞
79.8
75
*
130
Kela drug reimbursment
Malignant tumour
+∞
61.4
58
*
D29.0
ICD-10 Finland
Benign neoplasm: Penis
+∞
50.7
48
*
D40.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Testis
67.7
49.1
56
9
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
+∞
45.3
43
*
L02AE02
ATC
leuprorelin; implant, parenteral
+∞
45.3
43
*
KFC00
NOMESCO Finland
Unilateral orchiectomy
48.8
44.9
54
12
Y77
ICPC
Malignant neoplasm prostate
387.7
37.4
37
*
NK6AN
NOMESCO Finland
Total body bone isotope imaging
195.4
36.1
37
*
ZXC96
NOMESCO Finland
Robot assisted procedure
49.6
35.1
42
9
L02BB03
ATC
bicalutamide; oral
+∞
31.5
30
*
H02AB02
ATC
dexamethasone; systemic
26.9
31.4
43
17
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
29.4
28
*
A04AA02
ATC
granisetron; systemic, transdermal
+∞
29.4
28
*
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
7.7
29.2
70
100
WF002
NOMESCO Finland
Radical radiotherapy
104.5
27.9
30
*
KFD16
NOMESCO Finland
Partial excision of epididymis
52.2
25.4
30
6
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
60.5
25.2
29
5
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
6.9
24.7
63
99
22288
ICD-8 Finland
Benign neoplasm of male genital organs, Loco alio definito
+∞
24.1
23
*
22200
ICD-8 Finland
Benign neoplasm of male genital organs, Testis
+∞
24.1
23
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
248.4
23.8
24
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
23.0
22
*
XKD00
NOMESCO Finland
Uroflowmetry
2.6
22.9
199
923
UKC02
NOMESCO Finland
Cystoscopy
2.8
21.9
170
736
JN4BD
NOMESCO Finland
Extensive body CT
5.1
21.3
70
151
A03FA01
ATC
metoclopramide; systemic, rectal
4.0
21.1
89
246
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
62.1
21.0
24
*
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
6.8
20.8
53
83
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
2.7
20.3
160
693
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
108.2
19.7
21
*
KFA00
NOMESCO Finland
Exploration of testis
47.5
19.3
23
5
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
+∞
18.8
18
*
KCD02
NOMESCO Finland
Transurethral resection of bladder
39.6
18.7
23
6
WX408
NOMESCO Finland
General anesthesy, balanced
2.4
18.1
176
852
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
17.8
17
*
2223A
ICD-9 Finland
Benign neoplasm of male genital organs, Epididymis
+∞
16.7
16
*
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
174.1
16.6
17
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
15.7
15
*
9061/3-C62.9
ICD-O-3
Seminoma, NOS, of testis, NOS
+∞
15.7
15
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
15.7
15
*
KGB00
NOMESCO Finland
Biopsy of penis
87.1
15.6
17
*
XJH00
NOMESCO Finland
Transanal ultrasonography
3.2
15.1
85
294
G04BE03
ATC
sildenafil; oral
32.5
14.9
19
6
C62.11
ICD-10 Finland
Malignant tumor of the descending testicle, seminoma
+∞
14.6
14
*
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
+∞
14.6
14
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
14.6
14
*
22210
ICD-8 Finland
Benign neoplasm of male genital organs, Penis
+∞
14.6
14
*
KEC00
NOMESCO Finland
Retropubic radical prostatectomy
+∞
14.6
14
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
14.6
14
*
KE1BE
NOMESCO Finland
Rectal ultrasound examinaiton of prostata
2.6
14.4
113
482
N40
ICD-10 Finland
Hyperplasia of prostate
1.9
14.3
285
1854
J01MA02
ATC
ciprofloxacin; systemic
1.9
14.0
275
1773
J01DB01
ATC
cefalexin; oral
2.0
13.9
514
4150
2220A
ICD-9 Finland
Benign neoplasm of male genital organs, Testis
+∞
13.6
13
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
13.6
13
*
L01BC06
ATC
capecitabine; oral
+∞
13.6
13
*
7511
FHL
Orchidectomy (unilateral), also includes funicularectomy
+∞
13.6
13
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
29.0
13.0
17
6
N02AA05
ATC
oxycodone; systemic
2.7
12.8
90
361
22280
ICD-8 Finland
Benign neoplasm of male genital organs, Scroti
+∞
12.5
12
*
D29.9
ICD-10 Finland
Benign neoplasm: Male genital organ, unspecified
+∞
12.5
12
*
Z51.0
ICD-10 Finland
Radiotherapy session
+∞
12.5
12
*
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
4.2
12.5
47
117
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
132.4
12.5
13
*
JN4AD
NOMESCO Finland
Body CT examination
4.3
12.4
46
113
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.8
12.1
295
2020
Z51.5
ICD-10 Finland
Palliative care
5.8
11.9
33
59
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.8
11.9
80
311
D29.7
ICD-10 Finland
Benign neoplasm: Other male genital organs
+∞
11.5
11
*
PJA12
NOMESCO Finland
Sentinel node biopsy
+∞
11.5
11
*
L02BX02
ATC
degarelix; parenteral
+∞
11.5
11
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
11.5
11
*
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
+∞
11.5
11
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
2.0
11.1
166
953
R31
ICD-10 Finland
Unspecified haematuria
2.4
11.1
101
465
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
10.4
10
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
10.4
10
*
PJD44
NOMESCO Finland
Excision of iliac lymph nodes
+∞
10.4
10
*
B01AB05
ATC
enoxaparin; parenteral
1.9
10.4
169
993
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
8.4
10.4
22
27
TKE00
NOMESCO Finland
Needle biopsy of prostate
4.0
10.4
41
108
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
4.0
9.9
39
103
G03HA01
ATC
cyproterone; systemic
55.8
9.7
11
*
N02BE01
ATC
paracetamol; systemic, rectal
1.8
9.5
515
4357
XX3DW
NOMESCO Finland
Time consuming IT work
3.5
9.5
43
128
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
30.5
9.4
12
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
9.4
9
*
KC1GB
NOMESCO Finland
Cystography with X-ray
+∞
9.4
9
*
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
+∞
9.4
9
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
9.4
9
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
9.4
9
*
163
Kela drug reimbursment
Abiraterone and enzalutamide
+∞
9.4
9
*
A04AA01
ATC
ondansetron; systemic, rectal
7.9
9.2
20
26
R74.8
ICD-10 Finland
Abnormal levels of other serum enzymes
3.3
8.9
43
135
J01MA12
ATC
levofloxacin; systemic
1.9
8.7
131
743
JN4CD
NOMESCO Finland
Very extensive body CT
5.9
8.7
23
40
G04CA02
ATC
tamsulosin; oral
1.7
8.5
271
1948
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
8.3
8
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
8.3
8
*
L02BB04
ATC
enzalutamide; oral
+∞
8.3
8
*
JN5ER
NOMESCO Finland
PET-CT of receptors in whole body
+∞
8.3
8
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
8.3
8
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
8.3
8
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
8.3
8
*
ZX090
NOMESCO Finland
Other technic of radiotherapy
+∞
8.3
8
*
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.8
8.2
176
1129
D40.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Prostate
7.7
8.2
18
24
Y05
ICPC
Scrotum/testis sympt/compl other
5.5
7.9
22
41
S18
ICPC
Laceration/cut
1.6
7.8
256
1846
SPAT1153
SPAT
Removal of sutures
1.7
7.6
189
1260
7501
FHL
Testicular exploration (includes removal of biopsy, detorsion or appendix test)
18.6
7.6
11
6
L03AA02
ATC
filgrastim; parenteral
25.3
7.6
10
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
5.5
7.6
21
39
C05AA08
ATC
fluocortolone; rectal, topical
2.1
7.6
89
458
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
2.0
7.5
106
586
N43.4
ICD-10 Finland
Spermatocele
3.5
7.5
33
97
J01MA01
ATC
ofloxacin; systemic
2.3
7.5
66
299
K62.7
ICD-10 Finland
Radiation proctitis
80.9
7.4
8
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
80.9
7.4
8
*
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
80.9
7.4
8
*
J01EA01
ATC
trimethoprim; systemic
2.2
7.4
79
390
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
7.3
7
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
7.3
7
*
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
+∞
7.3
7
*
8140/3-C18.7
ICD-O-3
Adenocarcinoma, NOS, of sigmoid colon
+∞
7.3
7
*
C34.1
ICD-10 Finland
Malignant neoplasm: Upper lobe, bronchus or lung
+∞
7.3
7
*
KFC10
NOMESCO Finland
Bilateral orchiectomy
+∞
7.3
7
*
8312/3-C64.9
ICD-O-3
Renal cell carcinoma, NOS, of kidney, NOS
+∞
7.3
7
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
7.3
7
*
C60.9
ICD-10 Finland
Malignant neoplasm: Penis, unspecified
+∞
7.3
7
*
22299
ICD-8 Finland
Benign neoplasm of male genital organs, Unspecified site
+∞
7.3
7
*
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.6
7.2
248
1803
KFW96
NOMESCO Finland
Other operation on scrotum or scrotal organs
30.4
7.2
9
*
TKE10
NOMESCO Finland
Puncture of prostate
30.4
7.2
9
*
N02AX02
ATC
tramadol; systemic, rectal
1.6
7.2
253
1852
D41.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bladder
8.9
7.1
14
16
KEB00
NOMESCO Finland
Biopsy of prostate
8.9
7.1
14
16
N45.9
ICD-10 Finland
Orchitis, epididymitis and epididymo-orchitis without abscess
3.3
7.0
33
103
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
3.4
6.9
31
93
UJF32
NOMESCO Finland
Coloscopy
1.7
6.9
147
937
M02AA10
ATC
ketoprofen; topical
2.0
6.9
92
501
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
4.3
6.7
23
55
M05BX04
ATC
denosumab; parenteral
6.3
6.5
16
26
WX400
NOMESCO Finland
Inhalation anesthesy
4.0
6.4
24
62
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.9
6.4
37
132
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.8
6.4
118
717
D40.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other male genital organs
14.5
6.4
10
7
WX320
NOMESCO Finland
Spinalanesthesy
1.7
6.4
136
865
N50.8
ICD-10 Finland
Other specified disorders of male genital organs
8.3
6.4
13
16
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
6.3
169
1144
KE1BG
NOMESCO Finland
MRI of prostate
18.2
6.3
9
5
L03AA13
ATC
pegfilgrastim; parenteral
+∞
6.3
6
*
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
+∞
6.3
6
*
KFH50
NOMESCO Finland
Insertion of prosthetic replacement for testis
+∞
6.3
6
*
C60.1
ICD-10 Finland
Malignant neoplasm: Glans penis
+∞
6.3
6
*
WF090
NOMESCO Finland
Profylactic radiotherapy
+∞
6.3
6
*
C25.9
ICD-10 Finland
Malignant neoplasm: Pancreas, unspecified
+∞
6.3
6
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
6.3
6
*
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
6.3
6
*
C44.39
ICD-10 Finland
Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology
+∞
6.3
6
*
L02AE03
ATC
goserelin; implant
+∞
6.3
6
*
C60.0
ICD-10 Finland
Malignant neoplasm: Prepuce
+∞
6.3
6
*
KFD70
NOMESCO Finland
Excision of lesion of skin of scrotum
+∞
6.3
6
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
6.3
6
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.8
6.2
121
748
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
2.0
6.2
75
390
N39.3
ICD-10 Finland
Stress incontinence
12.7
6.1
10
8
G04CB02
ATC
dutasteride; oral
2.0
6.0
80
432
KDV10
NOMESCO Finland
Internal urethrotomy
5.3
6.0
17
33
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
131
576
2.55
18.92
4.7
2.7
231.2
236.8
u/l
0.30
125
540
372
2532
1.95
17.33
6.7
4.4
11.8
13.6
umol/l
2.83
359
2392
433
3183
1.87
15.14
5.1
3.7
142.9
258.3
e6/l
—
9
50
134
686
2.17
13.37
2.6
2.3
12.2
15.3
nmol/l
3.84
109
618
501
3974
1.81
12.47
8.7
5.6
78.2
77.1
u/l
0.22
467
3691
318
2231
1.75
12.02
4.1
3.8
—
—
—
0
0
509
4102
1.78
11.49
6.4
3.8
2.7
2.0
ug/l
0.76
444
3687
345
2522
1.69
10.91
8.1
6.2
1.2
1.2
mmol/l
0.18
277
2129
127
692
2.01
10.60
5.5
4.8
31.2
31.3
%
0.01
83
466
317
2316
1.65
9.71
7.2
5.8
1.2
1.2
mmol/l
0.76
278
2063
272
1928
1.65
9.28
3.9
3.0
—
—
—
0
0
416
3275
1.62
9.26
5.1
4.9
6.6
6.9
mmol/l
2.71
398
3084
366
2795
1.61
9.22
9.1
6.7
4.5
4.6
e9/l
0.13
328
2418
61
261
2.46
9.19
4.2
1.5
4.5
4.0
ug/l
0.11
53
196
231
1585
1.67
8.87
3.1
2.6
57.5
58.3
u/l
0.12
217
1475
606
5371
1.72
7.31
18.1
13.8
28.3
28.0
mg/l
0.06
503
4214
256
1881
1.55
7.10
2.8
2.7
184.1
187.4
ug/l
0.07
229
1712
36
135
2.75
7.09
1.7
1.4
6.3
4.8
u/l
0.44
26
113
229
1653
1.56
6.83
3.1
2.9
36.7
37.4
u/l
0.08
214
1559
51
231
2.30
6.80
2.1
1.5
—
—
—
0
0
287
2185
1.51
6.66
5.3
4.2
34.7
35.5
g/l
1.23
259
2003
173
1175
1.62
6.66
2.7
2.3
—
—
—
0
0
48
214
2.33
6.64
1.8
1.4
—
—
—
0
0
362
2913
1.48
6.29
2.4
2.5
—
—
—
0
0
200
1431
1.55
6.10
3.9
2.9
0.6
0.4
e6/l
0.26
161
1075
452
3813
1.48
6.09
4.3
3.7
12.8
11.4
mm/h
0.99
411
3499
527
4604
1.51
5.83
3.9
3.6
1.9
2.0
mu/l
0.90
461
4132
49
237
2.14
5.61
1.9
1.7
1.2
2.0
ug/l
0.52
37
209
74
417
1.86
5.53
3.1
2.1
0.2
0.2
g/l
0.14
68
366
122
801
1.63
5.32
4.1
2.9
0.8
0.8
mmol/l
1.36
113
747
236
1793
1.47
5.28
2.2
2.1
76.0
74.3
nmol/l
0.43
198
1562
111
719
1.64
5.10
2.9
2.7
22.1
24.1
%
0.90
96
613
65
361
1.88
5.09
1.4
1.5
—
—
—
0
0
620
5667
1.59
5.05
21.5
16.9
139.7
139.7
mmol/l
0.28
601
5504
138
946
1.56
5.01
1.7
1.8
—
—
—
0
0
116
764
1.62
4.98
2.7
2.6
2.1
2.2
g/l
0.95
103
707
181
1319
1.49
4.95
2.2
2.2
3.0
2.9
mg/l
0.36
153
1112
621
5688
1.58
4.90
21.6
17.0
4.0
4.0
mmol/l
0.71
602
5521
16
47
3.46
4.77
2.8
2.4
—
—
—
0
0
413
3520
1.39
4.67
3.4
3.1
56.2
55.8
u/l
0.03
381
3240
19
65
2.97
4.47
5.7
3.0
2.8
1.4
%
0.40
14
46
560
5050
1.45
4.46
17.5
12.6
77.8
78.6
ml/min/173m2
0.36
473
4114
51
274
1.93
4.43
5.1
3.6
24.0
24.7
mmol/l
1.19
44
252
121
834
1.54
4.27
2.7
2.6
12.2
13.1
umol/l
0.75
110
769
15
46
3.31
4.20
1.8
1.3
—
—
—
0
0
15
46
3.31
4.20
1.8
1.3
—
—
—
0
0
15
46
3.31
4.20
1.8
1.3
—
—
—
0
0
15
46
3.31
4.20
1.8
1.3
—
—
—
0
0
15
46
3.31
4.20
1.8
1.3
—
—
—
0
0
227
1778
1.40
4.13
2.3
2.2
293.8
329.4
u/l
0.13
213
1659
120
835
1.52
4.05
3.5
2.8
1.3
0.6
e6/l
0.75
77
472
229
1805
1.39
3.99
3.3
3.1
2101.7
1683.6
ng/l
0.51
190
1563
72
447
1.68
3.91
3.2
1.7
65.9
67.2
g/l
0.66
60
404
648
6063
1.57
3.89
27.0
19.8
138.0
141.2
g/l
4.70
636
5928
82
529
1.62
3.84
2.9
2.6
9.3
11.8
umol/l
0.33
71
471
68
422
1.67
3.70
3.0
2.4
34.5
45.9
u/l
0.51
61
355
9
16
5.68
3.66
2.4
1.2
—
—
—
0
0
9
16
5.68
3.66
2.4
1.2
—
—
—
0
0
9
16
5.68
3.66
2.4
1.2
—
—
—
0
0
9
16
5.68
3.66
2.4
1.2
—
—
—
0
0
281
2314
1.35
3.65
2.0
2.0
93.3
90.6
pmol/l
0.34
153
1295
281
2316
1.34
3.63
4.3
3.9
43.0
72.1
ng/l
0.90
220
1725
52
304
1.76
3.51
1.9
1.7
—
—
—
0
0
56
335
1.73
3.49
2.1
1.8
—
—
—
0
0
34
177
1.97
3.29
2.8
1.4
—
1.3
—
0
18
278
2317
1.32
3.24
3.6
2.7
0.7
0.7
ug/l
0.88
201
1527
401
3517
1.31
3.21
3.0
2.8
15.0
15.0
pmol/l
0.07
353
3124
48
282
1.75
3.21
1.3
1.6
1.7
1.5
g/l
0.93
39
239
21
91
2.35
3.20
1.8
1.3
—
—
—
0
0
121
892
1.43
3.04
3.2
2.6
1.1
0.8
e6/l
0.30
75
523
13
45
2.92
3.03
1.9
1.3
—
—
—
0
0
7
12
5.88
3.02
2.9
1.1
—
—
—
0
0
7
12
5.88
3.02
2.9
1.1
—
—
—
0
0
7
12
5.88
3.02
2.9
1.1
—
—
—
0
0
530
4850
1.33
3.02
17.7
14.9
41.3
41.0
%
0.35
337
3301
146
1115
1.39
3.00
1.8
1.8
1155.4
1132.1
nmol/l
0.08
101
853
618
5803
1.40
2.88
12.0
8.9
28.6
29.9
u/l
0.68
588
5550
102
740
1.44
2.80
7.9
6.2
1.1
1.0
mmol/l
0.86
94
690
8
18
4.48
2.80
2.8
3.0
—
—
—
0
0
23
112
2.09
2.70
1.8
1.6
—
—
—
0
0
18
79
2.31
2.69
2.0
1.6
—
—
—
0
0
54
346
1.61
2.65
1.6
1.5
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
34
192
1.81
2.63
2.1
2.7
0.3
0.3
u/ml
0.30
15
106
34
193
1.80
2.59
1.8
1.4
0.6
0.5
g/l
0.03
25
167
48
303
1.62
2.51
1.9
1.8
38.0
39.7
nmol/l
0.20
48
290
65
441
1.52
2.50
4.8
3.3
5.0
5.1
kpa
0.82
59
405
18
82
2.23
2.49
3.4
3.1
62.9
57.8
%
0.84
18
82
22
109
2.05
2.48
1.8
1.6
—
—
—
0
0
61
413
1.52
2.38
4.9
3.3
0.7
1.6
mmol/l
1.09
46
303
11
40
2.78
2.38
1.5
1.1
—
—
—
0
0
54
356
1.56
2.37
1.8
1.5
—
—
—
0
0
184
1511
1.29
2.28
3.9
2.1
2.3
2.3
mmol/l
0.25
152
1246
27
149
1.84
2.27
1.2
1.3
—
—
—
0
0
277
2395
1.25
2.24
5.1
4.2
0.0
0.0
estimate
0.00
58
413
371
3314
1.24
2.23
4.7
3.7
19.7
23.9
%
6.87
193
1549
166
1351
1.30
2.20
1.5
1.5
18.5
19.1
nmol/l
0.21
137
1136
17
80
2.15
2.20
3.2
3.0
5.1
4.5
e9/l
0.30
17
80
280
2431
1.24
2.17
3.9
3.1
0.0
0.0
estimate
0.00
55
380
9
30
3.02
2.15
1.3
1.3
—
—
—
0
0
63
440
1.47
2.14
4.3
2.5
60.9
63.9
ml/min/173m2
0.31
32
179
75
542
1.43
2.14
7.5
7.6
10.9
10.8
mmol/l
0.02
69
510
35
213
1.68
2.14
2.0
1.4
9.7
11.0
g/l
0.79
26
181
37
229
1.65
2.12
2.0
1.4
—
—
—
0
0
37
229
1.65
2.12
2.0
1.4
3.5
4.0
g/l
1.86
24
166
37
229
1.65
2.12
2.0
1.4
6.8
7.3
g/l
0.85
25
173
190
1581
1.27
2.11
3.2
2.6
2658.2
6906.8
umol/l
0.94
168
1375
8
25
3.22
2.10
1.4
1.3
—
—
—
0
0
8
25
3.22
2.10
1.4
1.3
—
—
—
0
0
51
343
1.52
2.08
4.9
4.6
109.9
110.2
ng/l
0.01
45
303
115
899
1.33
2.04
31.1
30.1
1.4
1.5
inr
0.22
12
125
35
216
1.65
2.04
2.3
3.1
—
—
—
0
0
578
5451
1.28
2.03
4.6
4.6
4.3
4.3
mmol/l
0.07
514
5039
97
740
1.36
2.02
8.3
6.8
—
—
—
0
0
276
2414
1.23
1.95
4.0
3.1
0.0
0.0
estimate
0.00
57
403
21
113
1.88
1.93
1.4
1.2
—
544.0
—
0
5
71
519
1.41
1.92
6.6
6.9
1.5
1.5
mmol/l
0.05
66
503
557
5243
1.26
1.91
4.2
4.2
1.3
1.4
mmol/l
0.21
490
4798
15
72
2.11
1.87
1.1
1.5
—
—
—
0
0
34
214
1.62
1.85
1.4
1.4
2.8
3.1
g/l
1.47
24
168
33
207
1.62
1.83
1.8
1.7
35.9
39.2
u/l
0.37
28
180
37
241
1.56
1.77
2.4
2.4
212.6
580.1
ug/l
1.24
32
230
8
30
2.68
1.72
1.4
1.3
—
—
—
0
0
10
42
2.40
1.68
2.3
1.2
—
—
—
0
0
10
42
2.40
1.68
2.3
1.2
—
—
—
0
0
10
42
2.40
1.68
2.3
1.2
—
—
—
0
0
29
181
1.63
1.66
1.3
1.4
37.9
37.5
g/l
0.09
22
153
563
5337
1.23
1.63
5.2
4.8
6.0
6.2
mmol/l
1.95
492
4823
19
106
1.81
1.60
2.5
1.8
14.2
11.5
mg/l
0.64
19
100
24
144
1.69
1.59
1.6
1.6
—
—
—
0
0
6
20
3.02
1.58
3.0
1.2
195.2
192.3
u/l
—
6
20
569
5406
1.23
1.58
4.8
4.6
1.3
1.3
mmol/l
0.96
508
4967
86
674
1.31
1.53
1.4
1.8
—
—
—
0
0
5
15
3.35
1.52
3.6
3.5
—
—
—
0
0
5
15
3.35
1.52
3.6
3.5
—
—
—
0
0
11
51
2.17
1.51
2.2
1.4
—
—
—
0
0
584
5572
1.23
1.51
5.0
5.2
2.6
2.6
mmol/l
0.16
520
5122
72
551
1.34
1.51
4.3
3.2
—
—
—
0
0
55
403
1.39
1.50
1.7
1.7
376.3
360.2
nmol/l
0.26
49
366
7
28
2.51
1.45
1.3
1.5
—
—
—
0
0
5
16
3.14
1.44
5.2
2.1
—
—
—
0
0
146
1232
1.23
1.43
1.7
1.8
112820946.8
29793915.5
pmol/l
0.51
117
1017
16
89
1.82
1.38
1.1
1.5
—
—
—
0
0
6
23
2.62
1.37
1.3
1.6
—
—
—
0
0
6
23
2.62
1.37
1.3
1.6
—
—
—
0
0
16
90
1.80
1.34
1.6
1.5
—
—
—
0
0
11
54
2.05
1.33
1.4
1.2
—
—
—
0
0
10
48
2.10
1.28
2.3
1.4
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
6
25
2.41
1.24
1.0
1.2
—
—
—
0
0
15
85
1.78
1.23
1.7
1.4
45.0
73.3
pmol/l
—
7
23
139
1186
1.21
1.23
3.9
3.9
218.3
646.5
ng/l
2.19
119
1007
5
19
2.64
1.22
3.0
1.3
0.2
0.2
nmol/l
—
5
13
21
132
1.61
1.21
1.2
1.4
—
—
—
0
0
156
1349
1.20
1.20
4.4
3.4
0.0
0.0
estimate
0.69
56
386
6
26
2.32
1.19
1.0
1.1
—
—
—
0
0
74
592
1.28
1.17
3.1
3.3
2.4
1.9
mmol/l
0.67
56
473
10
51
1.97
1.11
1.5
1.9
—
—
—
0
0
16
98
1.65
1.04
1.3
1.1
—
—
—
0
0
5
22
2.28
1.03
1.0
1.2
—
—
—
0
0
9
47
1.93
1.02
1.0
1.1
—
—
—
0
0
13
76
1.72
0.99
1.2
1.4
—
—
—
0
0
209
1882
1.15
0.98
4.2
3.3
—
—
—
0
0
7
37
1.90
0.94
1.4
1.6
—
—
—
0
0
537
5168
1.14
0.88
6.9
6.4
40.6
41.1
mmol/mol
0.60
469
4783
13
79
1.66
0.88
3.4
2.5
—
—
—
0
0
119
1036
1.18
0.87
1.6
1.7
1.3
1.3
mg/l
0.04
92
792
19
128
1.50
0.86
1.2
1.3
1.1
1.2
g/l
0.83
19
123
8
44
1.83
0.86
1.0
1.0
—
—
—
0
0
18
120
1.51
0.86
1.1
1.3
—
—
—
0
0
80
674
1.21
0.84
1.5
1.8
—
—
—
0
0
19
130
1.47
0.81
3.4
3.1
37.8
26.6
mg/l
0.26
11
90
7
39
1.80
0.72
1.6
1.9
—
—
—
0
0
17
118
1.45
0.69
1.1
1.1
—
—
—
0
0
11
70
1.58
0.65
1.2
1.4
—
—
—
0
0
19
137
1.40
0.65
1.6
2.4
3.5
3.6
g/l
0.09
19
126
450
4326
1.10
0.64
21.2
16.4
13.8
13.7
%
1.03
441
4200
11
71
1.56
0.62
3.6
2.4
—
—
—
0
0
10
63
1.60
0.62
1.0
1.1
—
—
—
0
0
11
72
1.54
0.59
1.2
1.5
1550.2
2224.5
e6/l
0.33
11
50
8
53
1.51
0.58
2.5
1.0
—
—
—
0
0
35
427
0.81
0.55
1.7
1.9
—
—
—
0
0
18
134
1.35
0.53
3.7
2.0
0.9
0.8
nmol/l
0.28
13
118
7
46
1.53
0.48
1.3
1.1
—
—
—
0
0
10
68
1.48
0.47
1.5
1.6
—
—
—
0
0
79
708
1.13
0.44
7.5
7.8
11.6
11.6
kpa
0.01
74
672
79
708
1.13
0.44
7.5
7.8
5.0
5.1
kpa
0.19
72
673
0
16
0.00
0.41
0.0
1.0
—
1429.8
—
0
16
134
1441
0.91
0.40
1.7
1.6
1.4
1.4
mmol/l
0.01
115
1191
0
18
0.00
0.40
0.0
1.7
—
—
—
0
0
78
704
1.12
0.40
7.7
7.9
1.3
1.0
mmol/l
0.23
65
533
76
685
1.12
0.40
1.2
1.2
53.8
34.2
iu/ml
0.27
22
194
20
161
1.25
0.37
1.5
1.5
—
—
—
0
0
8
116
0.69
0.37
1.0
1.1
—
6.7
—
0
11
6
45
1.34
0.34
1.2
1.3
—
—
—
0
0
36
314
1.15
0.32
2.4
2.9
25.1
25.1
mmol/l
0.03
36
304
62
566
1.10
0.28
1.7
1.3
—
—
—
0
0
17
205
0.83
0.28
3.2
2.2
101.2
137.4
ug/min
—
9
126
15
122
1.23
0.27
1.2
1.1
—
—
—
0
0
11
138
0.79
0.25
4.7
2.7
7.1
7.9
kpa
1.28
11
125
15
123
1.22
0.25
1.2
1.1
—
—
—
0
0
91
853
1.08
0.24
1.2
1.2
1.7
1.2
u/ml
0.20
23
250
15
179
0.83
0.23
1.9
1.6
—
—
—
0
0
69
643
1.08
0.22
1.3
1.2
2.6
10.3
u/ml
2.12
23
255
0
10
0.00
0.21
0.0
1.4
—
—
—
0
0
14
117
1.20
0.20
1.1
1.7
—
—
—
0
0
0
14
0.00
0.20
0.0
1.2
—
107.9
—
0
14
0
14
0.00
0.20
0.0
3.2
—
—
—
0
0
8
68
1.18
0.16
1.1
1.3
—
5.4
—
0
25
6
78
0.77
0.15
1.0
1.0
—
—
—
0
0
14
159
0.88
0.13
1.1
1.3
—
—
—
0
0
9
108
0.83
0.13
1.7
1.1
—
—
—
0
0
53
559
0.94
0.12
2.6
3.2
307.7
249.5
ng/l
0.26
47
520
15
133
1.13
0.12
1.7
2.0
—
—
—
0
0
193
1970
0.97
0.11
4.8
4.2
12.6
9.3
mg/mmol
0.26
129
1377
16
177
0.90
0.10
1.2
1.1
—
—
—
0
0
193
1965
0.98
0.09
3.9
3.4
8.1
8.7
mmol/l
1.10
153
1667
14
126
1.11
0.09
2.6
3.0
1.8
1.6
mmol/l
0.53
14
121
5
60
0.83
0.08
4.0
4.9
—
—
—
0
0
5
64
0.78
0.08
1.2
1.3
—
—
—
0
0
5
65
0.77
0.08
1.0
1.2
2.0
1.5
nmol/l
—
5
59
7
64
1.09
0.08
1.0
1.1
—
—
—
0
0
15
137
1.10
0.07
1.3
1.4
—
—
—
0
0
15
137
1.10
0.07
1.3
1.4
—
—
—
0
0
13
118
1.10
0.07
2.8
3.1
7.9
7.4
mmol/l
0.27
13
113
9
87
1.03
0.07
1.1
1.1
—
—
—
0
0
19
178
1.07
0.05
1.3
1.1
27.6
143.3
iu/ml
—
9
73
19
178
1.07
0.05
3.6
2.9
25.1
24.5
mmol/l
0.26
19
155
65
633
1.03
0.05
2.0
2.5
7.4
9.2
ug/l
0.55
51
562
85
861
0.99
0.02
4.2
2.1
2.5
2.4
mmol/l
1.29
76
724
27
262
1.03
0.02
1.1
1.3
293.9
304.6
u/ml
0.02
22
242
12
113
1.06
0.02
1.1
1.6
—
—
—
0
0
30
295
1.02
0.00
2.9
3.5
53.1
49.9
%
0.30
30
288
17
173
0.98
0.00
1.0
1.0
—
—
—
0
0
12
118
1.02
0.00
1.8
2.3
121.7
135.1
g/l
—
6
89
117
1167
1.00
0.00
4.7
3.4
1.0
1.0
kg/l
0.03
19
166
75
748
1.00
0.00
1.7
2.0
1.6
1.6
%
0.12
62
645
6
62
0.97
0.00
1.3
1.7
—
—
—
0
0
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
0
7
0.00
0.00
0.0
2.9
—
—
—
0
0
0
8
0.00
0.00
0.0
2.6
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
7
70
1.00
0.00
1.0
1.1
—
—
—
0
0
12
120
1.00
0.00
1.2
1.7
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
0.00
0.0
2.0
—
18.6
—
0
5
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_MALE_GEN_EXALLC – Benign neoplasm of male genital organs
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).